Mutant mice that lack serotonin(1A) receptors exhibit enhanced anxiety-rela
ted behaviors, a phenotype that is hypothesized to result from impaired aut
oinhibitory control of midbrain serotonergic neuronal firing. Here we exami
ned the impact of serotonin,, receptor deletion on forebrain serotonin neur
otransmission using in vivo microdialysis in the frontal cortex and ventral
hippocampus of serotonin(1A) receptor mutant and wild-type mice. Baseline
dialysate serotonin levels were significantly elevated in mutant animals as
compared with wild-types both in frontal cortex (mutant = 0.44 +/- 0.05 nM
; wild-type = 0.28 +/- 0.03 nM) and hippocampus (mutant = 0.46 +/- 0.07 nM;
wild-type = 0.27 +/- 0.04 nM). A stressor known to elicit enhanced anxiety
-like behaviors in serotonin(1A) receptor mutants increased dialysate 5-HT
levels in the frontal cortex of mutant mice by 144% while producing no alte
ration in cortical 5-HT in wild-type mice. There was no phenotypic differen
ce in the effect of this stressor on serotonin levels in the hippocampus. F
luoxetine produced significantly greater increases in dialysate 5-HT conten
t in serotonin(1A) receptor mutants as compared with wild-types, with two-
and three-fold greater responses being observed in the hippocampus and fron
tal cortex, respectively. This phenotypic effect was mimicked in wild-types
by pretreatment with the serotonin,, antagonist 4-iodo-N-[2-[4-(methoxyphe
nyl)-1-piperazinyl]ethyl]N-2-pyridinyl-benzamide (p-MPPI). These results in
dicate that deletion of central serotonin,A receptors results in a tonic di
sinhibition of central serotonin neurotransmission, with a greater dysregul
ation of serotonin release in the frontal cortex than ventral hippocampus u
nder conditions of stress or increased interstitial serotonin levels.